The funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and therapeutics providing broader and more durable protection against COVID-19 infection. BARDA, which helps companies develop medical supplies to address public health threats, is a part of HHS. The project is awarding up to $453 million to Vaxart for a study that will evaluate its oral COVID vaccine.

Related Keywords

Bengaluru , Karnataka , India , Shounak Dasgupta , Puyaan Singh , Biomedical Advanced Research , Reuters , Human Services , Us Department Of Health , Development Authority , Project Nextgen ,